Verteporfin

Verteporfin therapy is indicated for the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis. There is insufficient evidence to indicate Verteporfin for the treatment of predominantly occult subfoveal choroidal neovascularization.

brands

Filter:

Sort:

Brand NameDosage FormCompanyStrengthPrice

⊕Visudyne

Injection

Novartis (Bangladesh) Ltd.

2 mg/ml

৳15

per vial

1–1 of 1 brand

⚕

Always consult a registered doctor before taking any medicine. This information is for general knowledge only.